Medicines lobby says the PBS has not kept up with advances — or approvals — in medicines

8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (1 December 2023)

1 December 2023 - To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input ...

Read more →

New frontier will lead to better health outcomes

30 November 2023 - The Government has today tabled its response to an inquiry considering how to give Australian patients timely ...

Read more →

Publication of stage 1 and stage 2 PBS process improvements metrics report (2021-22)

21 April 2023 - The 2021-22 Stage 1 and Stage 2 PBS process improvements metrics report is now available. ...

Read more →

Price of a life: Australians wait two years longer for breakthrough medicines than US citizens

16 April 2023 - Australians are waiting two years longer to access new lifesaving subsidised medicines because of pharma giants. Now, ...

Read more →

Like Medicare, the PBS urgently needs overhauling – for all our sakes

10 February 2023 - Trent Zimmerman says it would be a mistake for Australia to narrow its health reform agenda ...

Read more →

Has there actually been early resolution for early resolution resubmissions?

15 September 2022 - Following on from this week's article on early re-entry resubmissions, today we took a close look ...

Read more →

Making #MedicinesMatter for all Australians

21 April 2022 - Medicines Australia has launched a social media campaign to highlight key policy issues for the election ...

Read more →

Faster patient access to new medicines must be a priority for next Government

10 April 2022 - With the Federal Election campaign now formally underway, Medicines Australia is reminding the major parties of ...

Read more →

National Medicines Policy too important to be rushed before Federal Election

10 February 2022 - Following consultation with members – and heeding the concerns of the Consumers Health Forum and patient ...

Read more →

Review of the National Medicines Policy – consultation on draft National Medicines Policy extended

8 February 2022 - The consultation period on the draft NMP was due to close on Wednesday 16 February 2022.  ...

Read more →

Medicines Australia calls for new National Medicines Policy to be pushed back until after the federal election

4 February 2022 - Medicines Australia is today calling for the new National Medicines Policy to be pushed back until ...

Read more →

Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

Pharmaceutical Benefits Scheme continued dispensing arrangements

5 November 2021 - The Australian Government has extended the Continued Dispensing emergency arrangements until 30 June 2022, when they ...

Read more →

Strategies for generic/biosimilar market entry in Australia

19 October 2021 - After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great ...

Read more →